| 1282530-99-7 Basic information More.. |
Product Name: | 1-[(Methylsulfonyl)Methyl]-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | Synonyms: | 1-(methanesulfonylmethyl)-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;1-Methanesulfonylmethyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-pyrazole;1-[(Methylsulfonyl)Methyl]-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;(1-((METHYLSULFONYL)METHYL)-1H-PYRAZOL-4-YL)BORONIC ACID PINACOL ESTER;1-(methylsulfonylmethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;1H-Pyrazole, 1-[(methylsulfonyl)methyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;1-[(Methylsulfonyl)methyl]pyrazole-4-boronic Acid Pinacol Ester | CAS: | 1282530-99-7 | MF: | C11H19BN2O4S | MW: | 286.16 | EINECS: | | Mol File: | 1282530-99-7.mol | |
Use
1-[(Methylsulfonyl)methyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole is used in the preparation of benzoxepin derivatives as P13K inhibitors in the treatment of cancer.
|
1282530-99-7
Recommend Suppliers |
|